Deep vein thrombosis of lower extremity
Conditions
Interventions
Experimental group:The filter of inferior vena cava will not be removed in the first stage.
Control group:One-stage removal of inferior vena cava filter
Sponsors
The Second Affiliated Hospital of South China University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) The patient's age is 18-60 years old; 2) The disease duration is less than or equal to 14 days; 3) The patient is diagnosed with unilateral iliofemoral segment (central or mixed) lower extremity DVT, and it is a total occlusive disease; 4) Voluntarily participate in this clinical trial and sign Informed consent.
Exclusion criteria
Exclusion criteria: 1) Those with contraindications or allergies to the use of contrast agents, anticoagulation and thrombolytic drugs; 2) History of active internal bleeding or cerebral infarction within the past 3 months; 3) Severe trauma within the past 4 weeks 4) Pregnancy; 5) Uncontrolled hypertension (systolic blood pressure>180mmHg, diastolic blood pressure>110mmHg); 6) Bacterial endocarditis; 7) Those with coagulation dysfunction; 8) Those who cannot follow the doctor's advice for anticoagulation after discharge; 9) patients with malignant tumors; 10) special cases such as double inferior vena cava.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of PTS;Incidence of Pulmonary Embolism; | — |
Countries
China
Contacts
Public ContactXiong Guozuo
The Second Affiliated Hospital of South China University
Outcome results
None listed